BTG3 and systemic lupus erythematosus: In 2019, the European League Against Rheumatism/American College of Rheumatology endorsed “positive ANA (titer ≥ 1:80 by HEp-2 immunofluorescence)” as an entry criterion for systemic lupus erythematosus (SLE) (1).